Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review

Wei Zhang, Deliang Ouyang, Zhangkan Huang, Xu Che

Open source

DOI
10.3389/fonc.2023.1085166
Published
2023-01-27
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2023.1085166,
  title = {Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review},
  author = {Wei Zhang and Deliang Ouyang and Zhangkan Huang and Xu Che},
  year = {2023},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2023.1085166},
  url = {https://doi.org/10.3389/fonc.2023.1085166}
}

RIS

TY  - JOUR
TI  - Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review
AU  - Wei Zhang
AU  - Deliang Ouyang
AU  - Zhangkan Huang
AU  - Xu Che
PY  - 2023
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2023.1085166
UR  - https://doi.org/10.3389/fonc.2023.1085166
ER  - 

APA

Zhang, W., Ouyang, D., Huang, Z., & Che, X. (2023). Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1085166

Source records